title: Extrapancreatic cholinergic nerves mediate cholecystokinin-stimulated pancreatic polypeptide release.
abstract: Although vagal cholinergic stimulation is the predominant regulatory mechanism governing the release of pancreatic polypeptide (PP), recent studies suggest that cholecystokinin (CCK) is also an important mediator. The present study examined the role of cholinergic neural pathways in the PP response to exogenous CCK-8 using a selectively denervated canine pancreas model. Chronic denervated pancreatic preparations were created in five dogs, while five dogs underwent sham laparotomy as controls. On study days, the fasted animals were infused intravenous CCK-8 (40 or 400 pmole/kg/hr) for 60 min both with and without atropine (20 micrograms/kg/hr). Plasma was collected at 20-min intervals and PP levels were determined by radioimmunoassay. CCK-8 elicited a dose-dependent increase in circulating PP in dogs with a neurally intact pancreas. Atropine and pancreatic denervation eliminated the PP response to CCK-8 at 40 pmole/kg/hr (P < 0.01) and inhibited the PP response to CCK-8 at 400 pmole/kg/hr (P < 0.05). The high dose of CCK-8 still elicited a small PP response in the denervated dogs (P < 0.05), which was subsequently abolished by the addition of atropine. These findings suggest that extrapancreatic cholinergic nerves are essential components of CCK-stimulated PP release, and that intrapancreatic cholinergic activity may play a limited role.
authors.affiliation: Department of Surgery, Cincinnati Department of Veterans Affairs Medical Center, Ohio 45220.
authors.forename: B W
authors.initials: BW
authors.lastname: Kuvshinoff
authors.forename: R J
authors.initials: RJ
authors.lastname: Brodish
authors.forename: A S
authors.initials: AS
authors.lastname: Fink
authors.forename: D W
authors.initials: DW
authors.lastname: McFadden
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors; D003714:Denervation; D020109:Devazepide; D004285:Dogs; D005402:Fistula; D007700:Kinetics; D010179:Pancreas / Q000187:drug effects / Q000294:innervation* / Q000378:metabolism; D010183:Pancreatic Ducts / Q000601:surgery*; D010191:Pancreatic Polypeptide / Q000097:blood / Q000378:metabolism*; D012844:Sincalide / Q000494:pharmacology*; D013270:Stomach / Q000601:surgery; D013997:Time Factors
chemical_list: D001570:Benzodiazepinones; D010191:Pancreatic Polypeptide; D001285:Atropine; D002766:Cholecystokinin; D020109:Devazepide; D012844:Sincalide